Pathstone Holdings LLC bought a new stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 524,739 shares of the company’s stock, valued at approximately $57,356,000. Other large investors have also recently […]
Mmbg Investment Advisors CO. decreased its holdings in Merck & Co., Inc. (NYSE:MRK – Free Report) by 2.1% in the 4th quarter, HoldingsChannel reports. The firm owned 22,563 shares of the company’s stock after selling 480 shares during the quarter. Mmbg Investment Advisors CO.’s holdings in Merck & Co., Inc. were worth $2,460,000 as of […]
RMB Capital Management LLC boosted its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 7.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 145,516 shares of the company’s stock after acquiring an additional 9,464 shares during the […]
/PRNewswire/ DelveInsight s Anti-Radiation Drugs Market Insights report provides the current and forecast market analysis, individual leading anti-radiation.
The rise in demand for anti-radiation drugs is mainly driven by several factors. These include the growing occurrence of side effects linked to cancer screening methods, heightened risks of